Moderate

RS3PE syndrome

Seronegative synovitis with pitting oedema · Rheumatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Remitting seronegative symmetrical synovitis with pitting oedema is an acute symmetrical polyarthritis of elderly patients with striking pitting oedema of the dorsum of the hands and feet. It is usually dramatically steroid-responsive but can be a paraneoplastic marker, warranting malignancy vigilance.

Red flags

  • Steroid-refractory disease (reconsider malignancy)
  • Weight loss, night sweats or lymphadenopathy
  • Evolution to erosive seropositive arthritis
  • Features of another connective tissue disease
  • Marked systemic upset

Assessment

Differential diagnosis

  • Elderly-onset rheumatoid arthritis
  • Polymyalgia rheumatica
  • Late-onset spondyloarthropathy
  • Crystal arthropathy
  • Paraneoplastic polyarthritis
  • Cellulitis / lymphoedema

Investigations

  • RF and anti-CCP (negative by definition)
  • CRP/ESR (raised)
  • FBC, U&E, LFTs, calcium
  • Radiographs (non-erosive)
  • Age/sex-appropriate malignancy screen (examination, bloods, imaging as indicated)
  • Ultrasound showing tenosynovitis and synovitis

Management

  • Recognise the classic picture: sudden symmetrical small-joint synovitis with boxing-glove pitting oedema of the hands in an older patient
  • Confirm seronegativity and raised inflammatory markers
  • Exclude infection and crystal disease
  • Undertake an age-appropriate malignancy screen given paraneoplastic associations
  • Start low-dose corticosteroid, which usually produces rapid dramatic improvement
  • Taper steroids over weeks to months as symptoms remit
  • Monitor for relapse or evolution into another rheumatic disease
  • Maintain malignancy surveillance if atypical or steroid-refractory

Drugs & doses

Prednisolone — 15-20 mg PO OD with rapid symptomatic response, then taper
Naproxen — 500 mg PO BD as adjunct for pain (with gastroprotection)
Hydroxychloroquine — 200-400 mg PO OD if relapsing on steroid taper
Methotrexate — 15 mg PO/SC weekly if steroid-dependent or relapsing

Disposition

Outpatient rheumatology management with steroids and malignancy vigilance; admission rarely needed.

Complications & pitfalls

  • Underlying occult malignancy (haematological or solid)
  • Relapse on steroid withdrawal
  • Progression to another defined rheumatic disease
  • Steroid-related adverse effects in the elderly

Exam pearls

  • Dramatic, often complete, response to low-dose steroids is characteristic
  • Pitting oedema over the dorsum of the hands/feet is the hallmark
  • Poor steroid response or systemic features should prompt malignancy work-up
  • Usually non-erosive with an excellent prognosis when idiopathic

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.